Accueil > Publications > Résultats de la recherche > [Genetic predisposition to breast and ovarian cancer: importance of test results].

[Genetic predisposition to breast and ovarian cancer: importance of test results].

 
Type de document
Articles dans des revues scientifiques
Titre original du chapitre
[Genetic predisposition to breast and ovarian cancer: importance of test results].
Auteurs physiques
Julian-Reynier, C.
Date d'édition
2011
Revue
Medecine Sciences ; 27 , 6-7 : 657-61. Review. French. PMID:21718651[PubMed - indexed for MEDLINE] ; doi: 10.1051/medsci/2011276019
Résumé du document en anglais
Abstract
Oncogenetic consultations and predictive BRCA1/2 testing are intertwined processes and the specific impact of these genetic tests if performed alone through direct-to-consumer offers remains unknown. Noteworthy, the expectations of patients vary with their own status, whether they are affected or not by breast cancer at the time genetic testing is performed. The prescription of genetic tests for BCRA mutations has doubled in France between 2003 and 2009. There is a consensus on the fact that genetic results disclosure led to a significant increase in the knowledge and understanding that the patients have of the genetic risk and also changed the medical follow-up of these patients. Evaluating the psychological burden of tests disclosure did not reveal any major distress in patients who are followed by high-quality multidisciplinary teams. Longitudinal cohorts studies have now evaluated the perception and behaviour of these patients, and observed sociodemographic as well as geographic and psychosocial differences both in the acceptation of prophylactic strategies such as surgery, and time to surgery.

Code bibliographique
11_S82
Fichiers

Accéder au document

© SESSTIMORS PACA - SIRSÉ PACA - SISTE PACAMentions légalesCrédits • Dernière mise à jour le 23/06/2017